KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Down 21.4% in January

KORU Medical Systems, Inc. (NASDAQ:KRMD) saw a significant drop in short interest in January. As of January 15th, there was short interest totaling 678,811 shares, a drop of 21.4% from the December 31st total of 864,104 shares. Based on an average daily volume of 148,229 shares, the days-to-cover ratio is presently 4.6 days. Currently, 1.8% of the company’s stock are sold short. Currently, 1.8% of the company’s stock are sold short. Based on an average daily volume of 148,229 shares, the days-to-cover ratio is presently 4.6 days.

KORU Medical Systems Stock Down 1.1%

Shares of NASDAQ:KRMD traded down $0.06 during trading hours on Friday, hitting $5.39. The company’s stock had a trading volume of 130,354 shares, compared to its average volume of 128,212. The firm’s fifty day moving average price is $5.74 and its 200 day moving average price is $4.59. KORU Medical Systems has a 52 week low of $1.86 and a 52 week high of $6.61. The company has a market capitalization of $249.66 million, a price-to-earnings ratio of -67.38 and a beta of 0.51. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.48 and a quick ratio of 1.92.

Institutional Investors Weigh In On KORU Medical Systems

Institutional investors and hedge funds have recently made changes to their positions in the stock. Lakewood Asset Management LLC increased its stake in shares of KORU Medical Systems by 2.8% in the 4th quarter. Lakewood Asset Management LLC now owns 73,945 shares of the company’s stock worth $430,000 after acquiring an additional 2,000 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in shares of KORU Medical Systems by 52.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock worth $39,000 after buying an additional 3,478 shares during the last quarter. White Pine Capital LLC lifted its holdings in KORU Medical Systems by 1.6% in the second quarter. White Pine Capital LLC now owns 225,425 shares of the company’s stock valued at $807,000 after acquiring an additional 3,526 shares during the last quarter. Police & Firemen s Retirement System of New Jersey purchased a new position in KORU Medical Systems in the second quarter worth approximately $30,000. Finally, Connor Clark & Lunn Investment Management Ltd. raised its position in KORU Medical Systems by 23.5% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 82,631 shares of the company’s stock valued at $296,000 after purchasing an additional 15,714 shares during the period. 58.60% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on KRMD. Lake Street Capital increased their price objective on KORU Medical Systems from $6.00 to $8.00 and gave the company a “buy” rating in a research note on Monday, December 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a report on Thursday, January 22nd. Canaccord Genuity Group raised their price target on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Wall Street Zen raised KORU Medical Systems from a “buy” rating to a “strong-buy” rating in a report on Monday, January 12th. Finally, Craig Hallum reaffirmed a “buy” rating and set a $7.00 price objective on shares of KORU Medical Systems in a research note on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, KORU Medical Systems presently has an average rating of “Moderate Buy” and an average price target of $6.13.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.